-2.95 (-0.20%) Cipla has informed that Cipla (EU), UK, wholly owned subsidiary of the Company has entered into a joint venture agreement with Jiangsu Acebright Pharmaceutical Co. (Acebright), China on 15th July 2019 for incorporation of a company (JV Co.) in China.
The above information is a part of company’s filings submitted to BSE.